LogicBio Therapeutics (LOGC) Misses Q4 EPS by 52c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Tax provision: 0
Today's EPS Names:
DIT, DPZ, WRB, More
EPS Growth %: +82.6%
Financial Fact:
Tax provision: 0
Today's EPS Names:
DIT, DPZ, WRB, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.52).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Domino's Pizza (DPZ) Misses Q2 EPS by 12c, Beats on Revenue
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $24 at Mizuho
- Cloudflare Inc. (NET) PT Raised to $330 at Citizens on Infrastructure Subsector Strength
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
